5-FU, the most widely used chemotherapy drug for GC, can increase the expression of PD-L1 in GC cells and reduce bone marrow mesenchymal stem cells, and then weaken the CSC dryness of tumor cell. This evidence concerns the gene CD274 and neoplasm.